The global healthcare industry continues to undergo rapid transformation, driven by advances in research, innovative treatment options, and rising awareness of critical diseases. Among these, the prostate cancer therapeutics market has emerged as a major area of focus. Valued at USD 12.70 billion in 2023, the market is projected to expand steadily, reaching USD 13.67 billion in 2024 and surging...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Ελληνικά
Tiếng Việt